文献速递脑血管病

病因未明脑出血的患病率、特征与结局:系统综述与荟萃分析

Prevalence, Characteristics, and Outcomes of Undetermined Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.
PubMed 文献 · Stroke · 2021-08-04

该系统综述与荟萃分析纳入24项研究、共15 828例自发性脑出血患者,评估病因未明脑出血的患病率、影像特征与临床结局。病因未明脑出血的合并患病率为18%(95%CI 13%–23%),短期死亡率达33%(95%CI 25%–42%),尽管血肿体积相对较小。

要点

  • 病因未明脑出血合并患病率为18%,在未采用病因导向分类的研究中升至22%。
  • 病因未明脑出血患者短期(3个月内)死亡率为33%,伴发脑室内出血率为38%。
  • 病因未明脑出血血肿体积(15.4 mL)小于高血压性小动脉病(16.2 mL)和脑淀粉样血管病(24.7 mL)。

核心结论

  • 在采用病因导向分类的研究中,约七分之一的自发性脑出血患者病因未明或隐源性,在未采用病因导向分类的研究中约为四分之一。
  • 病因未明脑出血尽管血肿体积相对较小,但短期死亡率较高。

研究设计与样本

  • 系统综述与荟萃分析,纳入24项涉及自发性脑出血患者的研究,共15 828例(平均年龄64.8岁;男性60.8%)。
  • 采用随机效应模型合并患病率,使用Cochran Q和I2统计量评估异质性。
  • 亚组分析基于是否采用病因导向脑出血分类、是否完成详细神经影像以及脑淀粉样血管病相关脑出血患者是否应用Boston标准。

主要发现

  • 高血压性小动脉病脑出血、病因未明脑出血和脑淀粉样血管病脑出血的合并患病率分别为50%(95%CI 43%–58%)、18%(95%CI 13%–23%)和12%(95%CI 7%–17%),亚组间P<0.001。
  • 脑出血体积在脑淀粉样血管病脑出血中最大(24.7 mL,95%CI 19.7–29.8),其次为高血压性小动脉病脑出血(16.2 mL,95%CI 10.9–21.5)和病因未明脑出血(15.4 mL,95%CI 6.2–24.5)。
  • 病因未明脑出血患者短期(3个月内)死亡率为33%(95%CI 25%–42%),伴发脑室内出血率为38%(95%CI 28%–48%)。
  • 未采用病因导向分类的研究中病因未明脑出血患病率更高(22%,95%CI 15%–29%)。
  • 是否完成详细神经影像评估对病因未明脑出血患病率无差异(P=0.62)。

关键数值与推荐

  • 病因未明脑出血合并患病率18%(95%CI 13%–23%),未采用病因导向分类的研究中为22%(95%CI 15%–29%)。
  • 病因未明脑出血短期(3个月内)死亡率为33%(95%CI 25%–42%),伴发脑室内出血率为38%(95%CI 28%–48%)。
  • 病因未明脑出血血肿体积为15.4 mL(95%CI 6.2–24.5)。

临床怎么用

  • 临床遇到自发性脑出血时应考虑病因导向分类评估,病因未明者约占18%–22%。
  • 病因未明脑出血患者血肿体积虽相对较小,但短期死亡风险高(33%),需密切监测与积极管理。

局限性

  • 研究间存在异质性,采用随机效应模型合并。
  • 亚组分析显示是否完成详细神经影像对病因未明脑出血患病率无显著影响(P=0.62)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: There are scarce data regarding the prevalence, characteristics and outcomes of intracerebral hemorrhage (ICH) of undetermined (unknown or cryptogenic) etiology. We sought to determine the prevalence, radiological characteristics, and clinical outcomes of undetermined ICH. METHODS: Systematic review and meta-analysis of studies involving patients with spontaneous ICH was conducted to primarily assess the prevalence and clinical-radiological characteristics of undetermined ICH. Additionally, we assessed the rates for ICH secondary to hypertensive arteriopathy and cerebral amyloid angiopathy. Subgroup analyses were performed based on the use of (1) etiology-oriented ICH classification, (2) detailed neuroimaging, and (3) Boston criteria among patients with cerebral amyloid angiopathy related ICH. We pooled the prevalence rates using random-effects models, and assessed the heterogeneity using Cochran Q and I2 statistics. RESULTS: We identified 24 studies comprising 15 828 spontaneous ICH patients (mean age, 64.8 years; men, 60.8%). The pooled prevalences of hypertensive arteriopathy ICH, undetermined ICH, and cerebral amyloid angiopathy ICH were 50% (95% CI, 43%–58%), 18% (95% CI, 13%–23%), and 12% (95% CI, 7%–17% [P<0.001 between subgroups]). The volume of ICH was the largest in cerebral amyloid angiopathy ICH (24.7 [95% CI, 19.7–29.8] mL), followed by hypertensive arteriopathy ICH (16.2 [95% CI, 10.9–21.5] mL) and undetermined ICH (15.4 [95% CI, 6.2–24.5] mL). Among patients with undetermined ICH, the rates of short-term mortality (within 3 months) and concomitant intraventricular hemorrhage were 33% (95% CI, 25%–42%) and 38% (95% CI, 28%–48%), respectively. Subgroup analysis demonstrated a higher rate of undetermined ICH among studies that did not use an etiology-oriented classification (22% [95% CI, 15%–29%]). No difference was observed between studies based on the completion of detailed neuroimaging to assess the rates of undetermined ICH (P=0.62). CONCLUSIONS: The etiology of spontaneous ICH remains unknown or cryptogenic among 1 in 7 patients in studies using etiology-oriented classification and among 1 in 4 patients in studies that avoid using etiology-oriented classification. The short-term mortality in undetermined ICH is high despite the relatively small ICH volume.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Malhotra K, Zompola C, Theodorou A, et al. Prevalence, Characteristics, and Outcomes of Undetermined Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. Stroke. 2021. PMID: 34344165. doi:10.1161/STROKEAHA.120.031471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。